Centene Corp (CNC)

Currency in USD
35.86
-0.54(-1.48%)
Closed·
35.80-0.06(-0.17%)
·

CNC Comments

fraudulent on the gov't tit stock. buy more idiots so i can win on the short. please do.
centene is a house of cards as "goodwill" is it's biggest asset. Centene is 100% on the gov't hit and cannot survive without tax-payer funds.
$37.00 (-7%)
earnings means a price drop, no matter what
Sold a chunk with good profits
46 to 8 soon. shorts are in and bears win
how did this played out?
It will play out great in August and end of the year. Centene is a house of cards at best.
pro badge
It was time for a proper rebounc and now bigger Investment firms qre getting into it too! Will end up between 55-60 by April when Q1 comes out.
pro badge
Great stock. Will go up like crazy soon I guess...
pro badge
will they have good earnings
pro badge
fair value 56.33$
Any idea for the future of this stock?
very high
Long $CNC @ 32.35. Holding core position into 2026.
Long $CNC @ 32.35.
Shorters are welcome. Buy and hold investors already bought. We need new buyers. Please short!
pro badge
me too. ill stay till 40...
pro badge
it will fly to 40 or 45
i bought after the 40% drop, and after i bought more to lower the average, i was quite in loss, but i didnt sell, today i am again positive. time to say Bye to this company. good luck guys!
Beginner mistake.
maybe he's just swing trading but not cutting losses
Congratulations guys !!!
Stoner wrong again, said CNC will be below 20 dollars Boom, above 36 month later. How wrong can one person be. Come out mushroom guy, Stoner dude.
Told ya all premarket almost 36 all the wisers here
Stoner dude said UNH will never touch 330 in august. 09.09.2025 Boom UNH 330. CNC was suppose to go 15, i hope nobody listens this ape.
centene on way down to $15, saki maki, gave highest ACA increases. priced themselves out of their only profitable LOB.
Jajajaja
CNC is oversold and the stock price should naturally recover to the range of $ 32 to $ 35
Raul Rica not a one of them that is virtually 100% reliant on government programs. centene has little product mix in their portfolio, and will get crushed in AC has Biden let advanced premium tax credits expire, and introduced the poison pill penalty for Part-d, MA plans that wont expire until 2027. add that to V-28 coding introduced in the inflation reduction act, and at least United has the assets and capital to fight these headwinds, but Centene does not.
sake maki at least I have the guts to put my short plays and thoughts to put my plays and rational to my thoughts and shorts, and have people asking me questions. you have nothing to offer, and dont have the guts to state anything meaningful. I also have the grace to congratulate others and accept my defeats, as I might have assumed to early with United 220 still in play. get some courage instead of naysayers, and by the way back up your thoughts with meaningful industry insights. as for Centene, they have $22B in carve-outs booked on their balance sheet, if you know how to read one that dont deal with liquidity.
sake maki Kom, you cant possible be saying this. have some guts kid
pro badge
Im still shorting this n will continue cuz market is emotional
yes I was long to $28, but this is a sub $20 stock year end and $15-$16 mid after Q2 call 2026
yes I was long to $28, but this is a sub $20 stock year end and $15-$16 mid after Q2 call 2026
Would not be better to start shorting this stock just before 3rd quarter results? It can still be recovering a bit more from now on.
shorted to $15 by March 2026. could easily go lower looking at the equities they list.
Weren't you long from 23,5?
Josep Maria Serarols Golobardes yes to $28. now Im short to sub $20 by end of year. Buffet moved an entire forward. Q3 and Q4 will be distrust for the whole industry and back down we all go.
the ACA market was left to die on the vine by Biden in 2026, which is when the real problems come into play for a rather large segment of CNC's portfolio. First expect similar results with the 2025 FY RA transfers (really bad and not much they can do about that) Second, with the Biden expiration of the Enhanced Premium Tax Credits, actuaries are back to square 1, the first 2 years of the ACA were off by 100%, maybe not that but 50 The ACA market segment most likely will turn into a high risk pool death spiral as only those that need care will purchase. expect huge membership losses. Reprice is an Actuarial code for "we guessed". Nobody knows how this will play out. As Q1 of 2026 comes around be prepared to short this stock to the hilt. Get those margin accounts going now. With substantial decreases to their Medicaid Membership and Catastrophic Q1 ACA results coming and even worse Q2 compound by Q1 and the release of the FY 2025 RA transfer report, Q3 and Q4 will be a real doozy.
Josep Maria Serarols Golobardes bTW I hope it goes to $54. everything is relative at any point.
Brian Stoner I hope so as well.
everyone thinks im against them but only am trying to make everyone money. I worked in Actuarial, Underwriting, and Product for +30 years. Also started up 4 healthplans and ran just about every segment. I know every carriers pain or glory as lived through it multiple times. short or long, im just try to help, have some fun and dink around in this space as a hobby. best of luck.
at least Centene is being honest, compared to UHC, with themselves for full year guidance in 2025
May it recover 34$ ?
I dont think so. if they just tread water that is where my position is.
$23.50 is my postion
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.